| Date Filed | Type | Description |
| 06/09/2023 |
4
| Milligan Sandra (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.26, valued at
$44.1k
|
|
| 05/08/2023 |
4
| Milligan Sandra (Head of Research & Development) has filed a Form 4 on Organon & Co.|
Txns:
| Paid exercise price by delivering 2,168 shares
@ $24.24, valued at
$52.6k
Exercised 4,984 restricted stock units
@ $0 |
|
| 05/03/2023 |
4
| Milligan Sandra (Head of Research & Development) has filed a Form 4 on Organon & Co.|
Txns:
| Paid exercise price by delivering 826 shares
@ $24.63, valued at
$20.3k
Exercised 1,899 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Milligan Sandra (Head of Research & Development) has filed a Form 4 on Organon & Co.|
Txns:
| Paid exercise price by delivering 2,115 shares
@ $23.09, valued at
$48.8k
Exercised 5,964 restricted stock units
@ $0
Granted 29,230 restricted stock units
@ $0
Granted 104,961 options to buy
@ $23.52, valued at
$2.5M
|
|
| 03/02/2023 |
4
| Milligan Sandra (Head of Research & Development) has filed a Form 4 on Organon & Co.|
Txns:
| Paid exercise price by delivering 2,346 shares
@ $25.09, valued at
$58.9k
Exercised 7,976 restricted stock units
@ $0 |
|
| 07/15/2022 |
4
| Milligan Sandra (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 30,000 options to buy
@ $7.02, valued at
$210.6k
|
|
| 05/05/2022 |
4
| Milligan Sandra (Head of Research & Development) has filed a Form 4 on Organon & Co.|
Txns:
| Paid exercise price by delivering 525 shares
@ $32.08, valued at
$16.8k
Paid exercise price by delivering 1,806 shares
@ $32.44, valued at
$58.6k
Exercised 1,842 restricted stock units
@ $0
Exercised 4,984 restricted stock units
@ $0 |
|
| 05/03/2022 |
4
| Milligan Sandra (Head of Research & Development) has filed a Form 4 on Organon & Co.|
Txns:
| Paid exercise price by delivering 540 shares
@ $32.33, valued at
$17.5k
Exercised 1,896 restricted stock units
@ $0 |
|
| 04/04/2022 |
4
| Milligan Sandra (Head of Research & Development) has filed a Form 4 on Organon & Co.|
Txns:
| Granted 17,892 restricted stock units
@ $0
Granted 55,114 options to buy
@ $34.93, valued at
$1.9M
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |